Diffuse exanthematous drug eruption associated with intravenous immunoglobulin. Issue 1 (2nd January 2021)

• Record Type: Journal Article
• Authors: Paudel, Anish; Basnet, Sijan; Tharu, Biswaraj; Bohra, Nidrit
• Is Part Of: Proceedings. Volume 34:Issue 1(2021)
• Page Start: 81
• Page End: 82
• Publication Date: 2021-01-02
• Subjects: Adverse event -- exanthematous drug eruption -- intravenous immunoglobulin; Medicine -- Periodicals; Medicine; Medicine -- Periodicals; Periodicals; Electronic journals; 616.005
• DOI: 10.1080/08998280.2020.1805672
• Languages: English
• ISSNs: 0899-8280

Abstract

Abstract: Diffuse exanthematous drug eruption due to intravenous immunoglobulin (IVIg) is a rare adverse event reported only in case reports. We present a case of a 71-year-old woman with a diffuse maculopapular rash 5 days after receiving an IVIg infusion for treatment of chronic inflammatory demyelinating polyneuropathy. She was managed conservatively with antihistamines; she was already receiving prednisone 25 mg daily as part of treatment for the neuropathy. The rash resolved over 2 weeks.